These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9642500)

  • 1. Please don't hi-jack "quality of life".
    Steiner TJ
    Cephalalgia; 1998 May; 18(4):227-8. PubMed ID: 9642500
    [No Abstract]   [Full Text] [Related]  

  • 2. Rizatriptan: a new milestone in migraine treatment. Introduction.
    Ferrari MD
    Cephalalgia; 2000; 20 Suppl 1():1. PubMed ID: 11078002
    [No Abstract]   [Full Text] [Related]  

  • 3. Rizatriptan: a new milestone in migraine treatment. Closing remarks.
    Pascual J
    Cephalalgia; 2000; 20 Suppl 1():19. PubMed ID: 11078006
    [No Abstract]   [Full Text] [Related]  

  • 4. Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine.
    Allen C; Dayno J; Lines C; McCarroll K
    Cephalalgia; 2001 Feb; 21(1):77. PubMed ID: 11298669
    [No Abstract]   [Full Text] [Related]  

  • 5. Rizatriptan in acute treatment of migraine: update on new comparative data.
    Goadsby PJ
    Cephalalgia; 2000; 20 Suppl 1():10-5. PubMed ID: 11078004
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral migraine drug approved for marketing.
    Am J Health Syst Pharm; 1998 Aug; 55(16):1656. PubMed ID: 9740896
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence-based migraine therapy.
    Lines C; Allen C; McCarroll K
    Cephalalgia; 2001 Nov; 21(9):932-3; author reply 933-4. PubMed ID: 11903292
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing the effect of triptans in migraine.
    Tfelt-Hansen P; Olesen J
    Lancet; 2006 Oct; 368(9544):1313-4. PubMed ID: 17046449
    [No Abstract]   [Full Text] [Related]  

  • 9. Rizatriptan 5mg is not efficacious for migraine in adolescents.
    Maizels M
    Headache; 2002 Sep; 42(8):839-40; author reply 840. PubMed ID: 12390657
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of rizatriptan and other triptans on stringent measures of efficacy.
    Rieder MJ
    Neurology; 2002 Sep; 59(5):787; author reply 788. PubMed ID: 12229911
    [No Abstract]   [Full Text] [Related]  

  • 11. [Meta-analysis of triptan treatment in migraine].
    Nakashima K; Takeshima T; Kowa H
    No To Shinkei; 2004 Sep; 56(9):747-52. PubMed ID: 15552863
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and tolerability of rizatriptan.
    Sakai F
    Cephalalgia; 2000; 20 Suppl 1():16-8. PubMed ID: 11078005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current topics: expectation for new triptans].
    Hashimoto S; Iwata M
    Nihon Naika Gakkai Zasshi; 2001 Apr; 90(4):654-8. PubMed ID: 11391915
    [No Abstract]   [Full Text] [Related]  

  • 14. What matters is not the differences between triptans, but the differences between patients.
    Saper JR
    Arch Neurol; 2001 Sep; 58(9):1481-2. PubMed ID: 11559323
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement in migraine-specific quality of life in a clinical trial of rizatriptan.
    Santanello NC; Polis AB; Hartmaier SL; Kramer MS; Block GA; Silberstein SD
    Cephalalgia; 1997 Dec; 17(8):867-72; discussion 800. PubMed ID: 9453276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New abortive agents for the treatment of migraine.
    Potrebic S; Raskin NH
    Adv Intern Med; 2001; 46():1-29. PubMed ID: 11147249
    [No Abstract]   [Full Text] [Related]  

  • 17. Case Report: Rizatriptan-Induced Ischemic Colitis.
    Fonseka GR; Kurchin A
    Headache; 2015; 55(7):1008-9. PubMed ID: 25881718
    [No Abstract]   [Full Text] [Related]  

  • 18. Determinants of migraine-specific quality of life.
    Santanello NC; Davies G; Allen C; Kramer M; Lipton R
    Cephalalgia; 2002 Oct; 22(8):680-5. PubMed ID: 12383065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Migraine].
    Kinderkrankenschwester; 2004 Dec; 23(12):492-5. PubMed ID: 15691096
    [No Abstract]   [Full Text] [Related]  

  • 20. Sum of Pain Intensity Differences (SPID) in migraine trials. A comment based on four rizatriptan trials.
    Tfelt-Hansen P; McCarroll K; Lines C
    Cephalalgia; 2002 Oct; 22(8):664-6. PubMed ID: 12383062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.